Lanthanide-based substrates and methods for determining clostridial toxin activity

Details for Australian Patent Application No. 2005287262 (hide)

Owner Allergan, Inc.

Inventors Aoki, Kei Roger; Gilmore, Marcella A.; Verhagen, Marc; Williams, Dudley J.; Steward, Lance E.

Agent Davies Collison Cave

Pub. Number AU-A-2005287262

PCT Pub. Number WO2006/033843

Priority 10/947,071 21.09.04 US

Filing date 7 September 2005

Wipo publication date 30 March 2006

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/033843 Priority application(s): WO2006/033843

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287263-4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators

2005287246-Fluid collection and testing device